T-Cell Leukemia Translocation Altered (TCTA) Peptide
TCTA
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all TCTA products
- TCTA (T-Cell Leukemia Translocation Altered (TCTA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IQLAWGFYGN TVTGLYHRPG LGGQNGSTPD GSTHFPSWEM AANEPLKTHR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TCTA antibody,
Alternative Names: TCTA control peptide, TCTA antibody Blocking Peptide, Anti-TCTA Blocking Peptide, T-Cell Leukemia Translocation Altered Gene Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- TCTA (T-Cell Leukemia Translocation Altered (TCTA))
- Synonyms
- PXYLT2 Peptide, XT-II Peptide, XT2 Peptide, xylT-II Peptide, 9130410M22Rik Peptide, AW553637 Peptide, C85065 Peptide, Tctal Peptide, wu:fb06g04 Peptide, zgc:92721 Peptide, xylosyltransferase 2 Peptide, T-cell leukemia translocation altered Peptide, T cell leukemia translocation altered gene Peptide, T-cell leukemia translocation altered S homeolog Peptide, T-cell leukemia translocation altered gene Peptide, XYLT2 Peptide, TCTA Peptide, Tcta Peptide, tcta.S Peptide, tcta Peptide
- Background
- A chromosomal aberration, translocation t(1,3)(p34,p21), involving TCTA is associated with T-cell acute lymphoblastic leukemia (T-ALL).
- Molecular Weight
- 11 kDa
-
You are here:
